bFGF and FGFR-3 immunoreactivity in the rat brain following systemic kainic acid administration at convulsant doses: localization of bFGF and FGFR-3 in reactive astrocytes, and FGFR-3 in reactive microglia

Brain Res. 1997 Mar 28;752(1-2):315-8. doi: 10.1016/s0006-8993(96)01308-x.

Abstract

Strong bFGF immunoreactivity was observed in reactive astrocytes, as shown by double-labeling immunohistochemistry of bFGF and GFAP, from days 7 up to 30 (last time point examined) following kainic acid (KA) injection at convulsant doses in the adult rat. bFGF was not found in OX-42-positive reactive microglia. A few reactive glia co-localized FGFR-3 and GFAP, whereas the majority of cells expressing FGFR-3 were OX-42-immunoreactive. This was further supported by the observation that only approximately 10% of reactive glia co-localized bFGF and FGFR-3. These results show that reactive astrocytes are a major source of bFGF during the subacute stages of tissue damage following KA injection and that reactive astrocytes and, most particularly, reactive microglia are putative targets of bFGF through FGFR-3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism*
  • Brain / cytology
  • Brain / metabolism*
  • Convulsants / pharmacology*
  • Fibroblast Growth Factor 2 / metabolism*
  • Immunohistochemistry
  • Kainic Acid / administration & dosage*
  • Kainic Acid / pharmacology
  • Microglia / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Fibroblast Growth Factor / metabolism*
  • Tissue Distribution

Substances

  • Convulsants
  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factor 2
  • Kainic Acid